TNXP: No AdCom Required for TNX-102 SL NDA…
TNXP READ THE FULL TNXP RESEARCH REPORT Business Update No Advisory Committee Meeting for TNX-102 SL NDA On March 24, 2025, ...
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
Investors interested in arranging a meeting with the Company’s management during the conference should contact the Jones Trading conference coordinator. A live webcast of the presentation can be found ...
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Launches TONIX ONETM Digital Platform To Transform Migraine Care
Tonix Pharmaceuticals (NASDAQ: TNXP) , a biopharmaceutical company advancing innovative therapies, announced the launch of TONIX ONETM, a fully integ ...
American Association of Individual Investors3d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Down 11.27%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 11.27%, which has investors questioning if this is right time to buy.
Biomednewsbreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision
Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining attention as it advances TNX-102 SL, a non-opioid investigational therapy for fibromyalgia, toward po ...
PharmiWeb3d
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...